https://www.esmo.org/. /Longer-Disease-free-Survival-in-Phase-III-Trial-of- Sunitinib-as-Adjuvant-Treatment-for-Kidney-CancerCachedRavaud said: “Sunitinib is a potential new option for adjuvant therapy in renal cell

https://www.seminoncol.org/article/S0093-7754(13)00079-1/fulltextTo date, no effective adjuvant treatment for renal cell carcinoma (RCC) has been

https://www.eurekaselect.com/. /adjuvant-therapy-for-renal-cell-carcinomCachedAdjuvant Therapy for Renal Cell Carcinoma. Pp. 113-139 (27). Sebastiano Buti,

tcr.amegroups.com/article/view/12472/htmlCachedMar 28, 2017 . More than 200,000 people worldwide are diagnosed with renal-cell carcinoma (

https://www.cancer.org/cancer/kidney-cancer/treating/by-stage.htmlCachedSimilarTreatment given after surgery is known as adjuvant therapy. Sunitinib can have

https://pdfs.semanticscholar.org/. /b1c0677ca87aea8e22a544abfbe6f2fe1362 .pdfCachedThere is a need for effective adjuvant treatment in renal cell carcinoma (RCC).

https://mdanderson.elsevierpure.com/. /adjuvant-therapy-for-renal-cell- carcinoma-targeted-approachesCachedCurrently, clinical trials with the new targeted therapies developed for RCC are

https://www.sciencedirect.com/science/article/pii/S0305737217301494Before TKi no adjuvant treatment has shown clinical efficacy in RCC. •. In

https://www.ncbi.nlm.nih.gov/pubmed/29186296Ann Oncol. 2018 Feb 1;29(2):324-331. doi: 10.1093/annonc/mdx743. Adjuvant

https://www.medscape.com/viewarticle/888805CachedNov 16, 2017 . The US Food and Drug Administration (FDA) has approved sunitinib malate (

https://academic.oup.com/annonc/article/29/2/324/4657192Nov 24, 2017 . Targeted therapy in metastatic RCC. . Consequently, the success of targeted therapies in the metastatic setting inspired testing them in the adjuvant setting in patients at high risk for tumor recurrence after nephrectomy.

https://www.onclive.com/. /optimizing-adjuvant-therapy-in-renal-cell- carcinomaCachedNov 19, 2017 . Optimizing Adjuvant Therapy in Renal Cell Carcinoma. . A few days before Capitanio's presentation, the FDA approved sunitinib (Sutent) as an adjuvant therapy in patients with RCC who have received nephrectomy and are at high risk for recurrence.

https://www.practiceupdate.com/. the. adjuvant-therapy. rcc/. /3CachedJun 11, 2018 . Dr. Pal: Welcome to ASCO 2018. My name is Monty Pal and I'm a medical

abstracts.asco.org/212/AbstView_212_206687.htmlCachedFeb 10, 2018 . Background: At this point in time, there is no approved adjuvant therapy (AT) for

https://www.centerwatch.com/. /renal-cell-carcinoma-study-atezolizumab-as- adjuvant/CachedClinical trial for Renal Cell Carcinoma , A Study of Atezolizumab as Adjuvant

https://www.fda.gov/drugs/informationondrugs/. /ucm585686.htmCachedNov 16, 2017 . The recommended dose of sunitinib malate for the adjuvant treatment of RCC is

https://europepmc.org/abstract/med/24969163Abstract: At the present time, the standard of care for patients who have received

https://www.renalandurologynews.com/. /rcc-adjuvant-therapy/. /628138/CachedDec 27, 2016 . Adjuvant treatments for RCC must be prioritized by physicians because ultimately

https://www.targetedonc.com/. therapy. /determining-a-role-for- neoadjuvantadjuvant-therapy-in-rccCachedMay 22, 2017 . Much research has been done to define the role of neoadjuvant and adjuvant

https://www.mdedge.com/. /renal-cell-carcinoma/fda-approves-sunitinib- malate-adjuvantNov 17, 2017 . The Food and Drug Administration has approved sunitinib malate for the

https://www.researchgate.net/. /246311541_Adjuvant_Therapy_in_Renal_ Cell_Carcinoma_Where_Are_WeSimilarMar 24, 2018 . Request PDF on ResearchGate | Adjuvant Therapy in Renal Cell Carcinoma:

https://www.urologiconcology.org/article/S1078-1439(16)00028. /abstractThe role of adjuvant therapy for renal cell carcinoma (RCC) after surgical

https://www.mountsinai.org/. /study-of-atezolizumab-as-adjuvant-therapy-in- participants-with-renal-cell-carcinoma-rcc-at-high-risk-of-developin. CachedA Study of Atezolizumab as Adjuvant Therapy in Participants With Renal Cell

https://www.jwatch.org/. /fda-approves-first-adjuvant-therapy-renal-cell- carcinomaCachedNov 20, 2017 . By Kelly Young Edited by Susan Sadoughi, MD, and André Sofair, MD, MPH The

https://www.mayo.edu/research/clinical-trials/cls-20366141CachedA Study of Atezolizumab as Adjuvant Therapy in Participants With Renal Cell

https://www.cancertherapyadvisor.com/renal-cell-carcinoma/renal-cell- carcinoma-rcc-adjuvant-therapy. /701001/CachedOct 18, 2017 . The armory of drugs available to patients with advanced renal cell carcinoma (

https://www.urmc.rochester.edu/health-research/open. /10506?. CachedKidney Cancer: A Study of Atezolizumab as Adjuvant Therapy in Participants

https://moh-it.pure.elsevier.com/. /adjuvant-therapy-in-renal-cell-carcinomaCachedNov 1, 2017 . In this review, we will summarize the main clinical trials investigating adjuvant

https://www.nejm.org/doi/full/10.1056/NEJMoa1611406Oct 10, 2016 . Among patients with locoregional clear-cell renal-cell carcinoma at high risk for .

https://www.journals.elsevierhealth.com/article/S0302-2838(16)30886. /pdfAdjuvant Therapy for Renal Cell Carcinoma. Axel Bex a,*, Laurence Albiges b,

https://www.cancertreatmentreviews.com/article/S0305. 4/abstract•Before TKi no adjuvant treatment has shown clinical efficacy in RCC. •In

www.hematologyandoncology.net/. /adjuvant-treatment-for-renal-cell- carcinoma-do-we-finally-have-a-major-breakthrough/CachedAn increasing list of available treatments for metastatic RCC continues to provide

https://www.pharmpro.com/. /pfizers-drug-approved-adjuvant-treatment- recurrent-renal-cell-carcinomaCachedNov 17, 2017 . Pfizer's Drug Approved As Adjuvant Treatment In Recurrent Renal . The current

https://www.urotoday.com/. /101897-asco-gu-2018-status-of-adjuvant- therapy-in-renal-cell-carcinoma-in-2018-completed-trials-and-what-. CachedFeb 11, 2018 . This discussion is particularly pertinent in light of the recent FDA-approval of

www.cancernetwork.com/renal-cell-carcinoma/fda-approves-adjuvant- therapy-high-risk-renal-cell-carcinomaCachedNov 17, 2017 . The FDA has approved a new indication for sunitinib (Sutent) to include the

https://www.uptodate.com/. /overview-of-the-treatment-of-renal-cell- carcinomaCachedJun 12, 2018 . Adjuvant Vascular Endothelial Growth Factor-targeted Therapy in Renal Cell

https://www.onclive.com/. /fda-approves-adjuvant-sunitinib-for-highrisk-rccCachedNov 16, 2017 . FDA Approves Adjuvant Sunitinib for High-Risk RCC. The FDA has approved sunitinib (Sutent) for use as an adjuvant therapy in patients with renal cell carcinoma (RCC) who have received nephrectomy and are high risk for recurrence.

https://grandroundsinurology.com/adjuvant-sunitinib-for-high-risk-renal-cell -carcinoma/CachedWell, I guess I'm not unfamiliar with debating myself, so I'll go ahead and talk to

www.ascopost.com/. /sunitinib-malate-for-adjuvant-treatment-of-renal-cell- carcinoma/CachedDec 25, 2017 . On November 16, 2017, sunitinib malate (Sutent) was approved for the adjuvant

https://link.springer.com/chapter/10.1007/978-1-60327-149-3_18A series of adjuvant studies are reviewed that have been conducted in patients

https://clinicaltrials.gov/ct2/show/NCT01649180CachedNEXT: Subsequent Exposure to Tyrosine Kinase Inhibition at Recurrence After

press.pfizer.com/. /pfizer-provides-update-phase-3-trial-axitinib-adjuvant- treatment-patients-high-risk-reCachedApr 10, 2018 . Pfizer Provides Update on Phase 3 Trial of Axitinib as Adjuvant Treatment for

https://www.tandfonline.com/doi/abs/10.1080/14737140.2018.1469980May 14, 2018 . Introduction: Locally advanced, non-metastatic renal cell carcinoma (RCC) is

https://www.gotoper.com/. /emerging-paradigm-shifts-in-renal-cell- carcinoma-a-critical-assessment-of-adjuvant-treatment-dataCachedHowever, the use of adjuvant therapy for RCC remains an area of controversy.

urology.ucla.edu/iuo/phase-iii-study-in-adjuvant-therapyCachedShare this. Phase III study in Adjuvant Therapy in Renal Cell Carcinoma patients

https://www.europeanurology.com/article/S0302-2838(16)30726-6/pdfSurgery is the gold standard treatment for patients with localized and locally

https://www.cancer.gov/about-cancer/treatment/clinical-trials/. /v?. CachedA Study of Atezolizumab as Adjuvant Therapy in Participants With Renal Cell

Sitemap